Is the dose used the dose tested?

M. Packer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Clinical trial results are not readily adopted into everyday clinical practice. Despite the publication of numerous clinical studies, many findings still continue to be ignored, misunderstood or remain unknown by physicians. In clinical trials, drug dosing and timing are carefully planned and rigorously applied. In clinical practice, however, physicians rarely use the doses that are reported to be associated with benefit. In general, physicians measure physiological variables and titrate drug doses to attain a therapeutic effect. Most physicians begin with a low dose in the belief that the desired effect may be achieved without any toxic effects. However, underdosing may deny the chance of benefit.

Original languageEnglish (US)
Pages (from-to)2-6
Number of pages5
JournalCardiology
Volume85
Issue numberSUPPL. 1
StatePublished - 1994

Fingerprint

Physicians
Clinical Trials
Poisons
Therapeutic Uses
Pharmaceutical Preparations
Publications
Clinical Studies

Keywords

  • Clinical trials
  • Dose testing
  • Drug utilization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Packer, M. (1994). Is the dose used the dose tested? Cardiology, 85(SUPPL. 1), 2-6.

Is the dose used the dose tested? / Packer, M.

In: Cardiology, Vol. 85, No. SUPPL. 1, 1994, p. 2-6.

Research output: Contribution to journalArticle

Packer, M 1994, 'Is the dose used the dose tested?', Cardiology, vol. 85, no. SUPPL. 1, pp. 2-6.
Packer M. Is the dose used the dose tested? Cardiology. 1994;85(SUPPL. 1):2-6.
Packer, M. / Is the dose used the dose tested?. In: Cardiology. 1994 ; Vol. 85, No. SUPPL. 1. pp. 2-6.
@article{45c6ca8f0a12455f8998718723141695,
title = "Is the dose used the dose tested?",
abstract = "Clinical trial results are not readily adopted into everyday clinical practice. Despite the publication of numerous clinical studies, many findings still continue to be ignored, misunderstood or remain unknown by physicians. In clinical trials, drug dosing and timing are carefully planned and rigorously applied. In clinical practice, however, physicians rarely use the doses that are reported to be associated with benefit. In general, physicians measure physiological variables and titrate drug doses to attain a therapeutic effect. Most physicians begin with a low dose in the belief that the desired effect may be achieved without any toxic effects. However, underdosing may deny the chance of benefit.",
keywords = "Clinical trials, Dose testing, Drug utilization",
author = "M. Packer",
year = "1994",
language = "English (US)",
volume = "85",
pages = "2--6",
journal = "Cardiologia",
issn = "1558-2027",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Is the dose used the dose tested?

AU - Packer, M.

PY - 1994

Y1 - 1994

N2 - Clinical trial results are not readily adopted into everyday clinical practice. Despite the publication of numerous clinical studies, many findings still continue to be ignored, misunderstood or remain unknown by physicians. In clinical trials, drug dosing and timing are carefully planned and rigorously applied. In clinical practice, however, physicians rarely use the doses that are reported to be associated with benefit. In general, physicians measure physiological variables and titrate drug doses to attain a therapeutic effect. Most physicians begin with a low dose in the belief that the desired effect may be achieved without any toxic effects. However, underdosing may deny the chance of benefit.

AB - Clinical trial results are not readily adopted into everyday clinical practice. Despite the publication of numerous clinical studies, many findings still continue to be ignored, misunderstood or remain unknown by physicians. In clinical trials, drug dosing and timing are carefully planned and rigorously applied. In clinical practice, however, physicians rarely use the doses that are reported to be associated with benefit. In general, physicians measure physiological variables and titrate drug doses to attain a therapeutic effect. Most physicians begin with a low dose in the belief that the desired effect may be achieved without any toxic effects. However, underdosing may deny the chance of benefit.

KW - Clinical trials

KW - Dose testing

KW - Drug utilization

UR - http://www.scopus.com/inward/record.url?scp=0028633616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028633616&partnerID=8YFLogxK

M3 - Article

VL - 85

SP - 2

EP - 6

JO - Cardiologia

JF - Cardiologia

SN - 1558-2027

IS - SUPPL. 1

ER -